Der Gynäkologe

, Volume 47, Issue 2, pp 104–110

Transsexualität – Gender-Dysphorie

Leitthema

Zusammenfassung

In den vergangenen Jahren hat sich der Blick auf das Phänomen der Transsexualität international drastisch verändert. Wir sprechen nunmehr von Gender-Dysphorie in unterschiedlichen Ausprägungsformen. Die Notwendigkeit einer Behandlung bezieht sich auf eine Besserung der Dysphorie und ist daher als sehr individuell anzusehen. Die wohl am stärksten ausgeprägte Form der Gender-Dysphorie ist die Transsexualität. Somatische Behandlungsschritte im Sinne von gegengeschlechtlicher Hormonbehandlung und geschlechtsangleichender Operation sind in diesen Fällen jene therapeutischen Schritte, die eine Verbesserung der Lebensqualität der Betroffenen erzielen. Nach Diagnosestellung durch Psychiater, Psychologen sowie Psychotherapeuten und entsprechender Indikationsstellung werden Ärzte diverser Disziplinen, so auch Gynäkologen und Endokrinologen, in den Behandlungsprozess involviert. Eine interdisziplinäre Zusammenarbeit mit Kollegen anderer Fachrichtungen, etwa Urologie, plastische Chirurgie etc., ist wichtig und sinnvoll. Im Beitrag soll ein kurzer Überblick über einige neue Aspekte der Gender-Dysphorie und der Behandlung der Transsexualität aufgezeigt werden.

Schlüsselwörter

Geschlechtsangleichung Gender-Identität Hormontherapie Gender-Identitätsstörungen Gender-Reassignement-Verfahren 

Transsexuality – Gender dysphoria

Abstract

In the recent past the international perspective on the phenomenon of transsexuality has drastically changed and is now referred to as gender dysphoria in various forms of expression. The necessity for treatment refers to an improvement of dysphoria and must therefore be viewed very individually. The most extremely expressed form of gender dysphoria is transsexuality. Somatic treatment steps in the sense of opposite gender hormone treatment and gender change operations are in such cases those therapeutic steps which can achieve an improvement in the quality of life of persons affected. After a diagnosis has been made and the indications for these treatment steps have been established by psychiatrists, psychologists and psychotherapists, medical specialists from diverse disciplines as well as gynecologists and endocrinologists become involved in the treatment process. Interdisciplinary cooperation with other specialist disciplines, such as urology and plastic surgery is important and makes sense. This article presents a brief review of some new aspects of gender dysphoria and the treatment of transsexuality.

Keywords

Gender change Gender identity Hormone therapy Sexual and gender disorders Sex reassignment procedures 

Literatur

  1. 1.
    The Yogyakarta principles on the application of international human rights law in relation to sexual orientation and gender identity. http://www.yogyakartaprinciples.org
  2. 2.
    American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington, VA Google Scholar
  3. 3.
    Kesteren PJ van, Gooren LJ, Megens JA (1996) An epidemiological and demographic study of transsexuals in The Netherlands. Arch Sex Behav 25:589–600CrossRefPubMedGoogle Scholar
  4. 4.
    Zhou JN, Hofman MA, Gooren LJ, Swaab DF (1995) A sex difference in the human brain and its relation to transsexuality. Nature 378:68–70CrossRefPubMedGoogle Scholar
  5. 5.
    Swaab DF, Chung WC, Kruijver FP et al (2002) Sexual differentiation of the human hypothalamus. Adv Exp Med Biol 511:75–100CrossRefPubMedGoogle Scholar
  6. 6.
    Coleman E, Bockting W, Botzer M et al. (2011) Standards of care for the health of transsexual, transgender, and gender nonconforming people, version 7. Int J Transgenderism 13:165−232. http://www.wpath.org/uploaded_files/140/files/IJT%20SOC,%20V7.pdf (Zugegriffen: 12.12.2013)
  7. 7.
    Gooren L (2005) Hormone treatment of the adult transsexual patient. Horm Res 64 (Suppl 2):31–36CrossRefPubMedGoogle Scholar
  8. 8.
    Becerra Fernández A, Luis Román DA de, Piédrola Maroto G (1999) Morbidity in transsexual patients with cross-gender hormone self-treatment. Med Clin (Barc) 113:484–487Google Scholar
  9. 9.
    Moore E, Wisniewski A, Dobs A (2003) Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab 88:3467–3473CrossRefPubMedGoogle Scholar
  10. 10.
    Asscheman H, Giltay EJ, Megens JA et al (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635–642. doi:10.1530/EJE-10-1038CrossRefPubMedGoogle Scholar
  11. 11.
    Karim RB, Hage JJ, Mulder JW (1996) Neovaginoplasty in male transsexuals: review of surgical techniques and recommendations regarding eligibility. Ann Plast Surg 37:669–675CrossRefPubMedGoogle Scholar
  12. 12.
    Kesteren P van, Lips P, Gooren LJ et al (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 48:347–354Google Scholar
  13. 13.
    Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K (2005) Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study. Osteoporos Int 16:791–798CrossRefPubMedGoogle Scholar
  14. 14.
    Elamin MB, Garcia MZ, Murad MH et al (2010) Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 72:1–10. doi:10.1111/j.1365-2265.2009.03632.xGoogle Scholar
  15. 15.
    Gooren LJ, Trotsenburg MA van, Giltay EJ, Diest PJ van (2013) Breast cancer development in transsexual subjects receiving cross-sex hormone treatment. J Sex Med. doi:10.1111/jsm.12319Google Scholar
  16. 16.
    Gooren LJ, Giltay EJ (2008) Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females. J Sex Med 5:765–776CrossRefPubMedGoogle Scholar
  17. 17.
    Giltay EJ, Gooren LJ (2000) Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 85:2913–2921CrossRefPubMedGoogle Scholar
  18. 18.
    Wierckx K, Elaut E, Van Caenegem E et al (2011) Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration. Eur J Endocrinol 165:331–337. doi:10.1530/EJE-11-0250 (Epub 2011 May 20)CrossRefPubMedGoogle Scholar
  19. 19.
    Slagter MH, Gooren LJ, Scorilas A et al (2006) Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J Histochem Cytochem 54:905–910CrossRefPubMedGoogle Scholar
  20. 20.
    Ott J, Trotsenburg M van, Kaufmann U et al (2010) Combined hysterectomy/salpingo-oophorectomy and mastectomy is a safe and valuable procedure for female-to-male transsexuals. J Sex Med 7:2130–2138. doi:10.1111/j.1743-6109.2010.01719.xCrossRefPubMedGoogle Scholar
  21. 21.
    Hage JJ (1996) Metaidoioplasty: an alternative phalloplasty technique in transsexuals. Plast Reconstr Surg 97:161–167CrossRefPubMedGoogle Scholar
  22. 22.
    Monstrey SJ, Ceulemans P, Hoebeke P (2011) Sex reassignment surgery in the female-to-male transsexual. Semin Plast Surg 25:229–244. doi:10.1055/s-0031-1281493PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Pototschnig H, Schaff J, Kovacs L et al (2013) The free osteofasciocutaneous fibula flap: clinical applications and surgical considerations. Injury. pii: S0020-1383(13)00019-3. doi:10.1016/j.injury.2013.01.007Google Scholar
  24. 24.
    Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA et al (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154. doi:10.1210/jc.2009-0345CrossRefPubMedGoogle Scholar
  25. 25.
    Lawrence AA (2003) Factors associated with satisfaction or regret following male-to-female sex reassignment surgery. Arch Sex Behav 32:299–315CrossRefPubMedGoogle Scholar
  26. 26.
    Wierckx K, Van Caenegem E, Elaut E et al (2011) Quality of life and sexual health after sex reassignment surgery in transsexual men. J Sex Med 8:3379–3388. doi:10.1111/j.1743-6109.2011.02348.xCrossRefPubMedGoogle Scholar
  27. 27.
    Murad MH, Elamin MB, Garcia MZ (2010) Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 72:214–231. doi:10.1111/j.1365-2265.2009.03625.xGoogle Scholar
  28. 28.
    Sohn MH, Hatzinger M, Wirsam K (2013) Genital reassignment surgery in male-to-female transsexuals: do we have guidelines or standards? Handchir Mikrochir Plast Chir 45:207–210. doi:10.1055/s-0033-1343427 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Abteilung für gynäkologische Endokrinologie und Reproduktionsmedizin und Abteilung für Geburtshilfe und Fetomaternale MedizinMedizinische Universität Wien – FrauenklinikWienÖsterreich

Personalised recommendations